hexamethonium has been researched along with Palsy in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fruhwald, S | 1 |
| Herk, E | 1 |
| Hammer, HF | 1 |
| Holzer, P | 1 |
| Metzler, H | 1 |
| Jung, R | 1 |
| Katona, PG | 1 |
2 other studies available for hexamethonium and Palsy
| Article | Year |
|---|---|
Differential reversal of drug-induced small bowel paralysis by cerulein and neostigmine.
Topics: Adjuvants, Anesthesia; Adrenergic Agonists; Animals; Atropine; Ceruletide; Dose-Response Relationshi | 2004 |
Cardiovascular and respiratory responses to slow ramp carotid sinus pressures in the dog.
Topics: Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Carotid Arteries; Carotid Sinus; Do | 1990 |